PathologyWatch Raises $25M in Series B Funding
- PathologyWatch, a Salt Lake City, UT-based digital lab and pathology platform for dermatologists, raised $25M in Series B financing
- Backers included Ceros Capital Markets, Rock Creek Capital, SpringTide, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group, and existing investors
- The company provides fully interfaced EMR reporting and 24/7 access to digital slides for dermatology clinics
- For their clients, this means more efficient workflows and direct access to dermatopathologists across the country, with broad insurance coverage
- The company has integrated laboratory information systems, scanners, digital viewer technology, and EMRs into an end-to-end solution for dermatologists
